Cell Biology Quiz: Cyclins And Cdks
20 questions · exam conditions
0:00
Cyclins And CdksQuestion 1 of 20

A researcher observes that cyclin B levels remain elevated in cells treated with a proteasome inhibitor during mitosis. However, these cells fail to progress from metaphase to anaphase despite having active Cdk1. Which of the following best explains this observation?

Cyclin B-Cdk1 complexes cannot form when proteasome function is inhibited, preventing chromosome separation
Elevated cyclin B levels create negative feedback that inactivates Cdk1 kinase activity required for anaphase
The spindle checkpoint remains active because securin cannot be degraded to release separase enzyme
High cyclin B concentrations sequester all available Cdk1, preventing formation of cyclin A-Cdk1 complexes
Proteasome inhibition blocks cyclin B nuclear export, which is required for chromosome condensation
← Back to quizzes

Cell Biology Quiz

Cell Biology Quiz: Cyclins And Cdks

Practice Cyclins And Cdks in Cell Biology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Cyclins And Cdks, giving you a quick way to practice the rules, question types, and explanations that matter most for Cell Biology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A researcher observes that cyclin B levels remain elevated in cells treated with a proteasome inhibitor during mitosis. However, these cells fail to progress from metaphase to anaphase despite having active Cdk1. Which of the following best explains this observation?

  1. Cyclin B-Cdk1 complexes cannot form when proteasome function is inhibited, preventing chromosome separation
  2. Elevated cyclin B levels create negative feedback that inactivates Cdk1 kinase activity required for anaphase
  3. The spindle checkpoint remains active because securin cannot be degraded to release separase enzyme (correct answer)
  4. High cyclin B concentrations sequester all available Cdk1, preventing formation of cyclin A-Cdk1 complexes
  5. Proteasome inhibition blocks cyclin B nuclear export, which is required for chromosome condensation
Explanation: When you encounter questions about cell cycle arrest during mitosis, focus on the regulatory mechanisms that control progression between phases, especially the spindle checkpoint system. The key insight here is understanding what happens at the metaphase-to-anaphase transition. For cells to exit metaphase, sister chromatids must separate, which requires the enzyme separase to cleave the cohesin proteins holding chromosomes together. However, separase is normally inhibited by a protein called securin. The spindle checkpoint prevents anaphase until all chromosomes are properly attached to spindle fibers, and this checkpoint works by preventing securin degradation. Since the proteasome is responsible for degrading securin, inhibiting it means securin cannot be broken down. Without securin degradation, separase remains inactive, sister chromatids cannot separate, and cells arrest in metaphase despite having active Cdk1. This explains why cyclin B levels stay high (it's also degraded by the proteasome) but anaphase still cannot proceed. Looking at the wrong answers: A is incorrect because cyclin B-Cdk1 complexes can still form regardless of proteasome function. B misrepresents the relationship between cyclin B levels and Cdk1 activity—high cyclin B doesn't create negative feedback on Cdk1. D incorrectly suggests that cyclin A-Cdk1 is needed for anaphase progression, when the real issue is securin-separase regulation. Remember: metaphase-to-anaphase transition depends on proper chromosome attachment AND proteasome-mediated protein degradation. Both must occur for cell division to proceed normally.

Question 2

In a cell culture experiment, cells are treated with a compound that prevents p21 protein degradation. If these cells are subsequently exposed to DNA damage, which outcome would most likely occur compared to untreated controls?

  1. Enhanced G1/S transition due to stabilized p21 promoting cyclin E-Cdk2 complex formation
  2. Accelerated cell cycle progression because accumulated p21 activates checkpoint kinase pathways
  3. Prolonged G1 arrest because stabilized p21 maintains inhibition of cyclin-Cdk complexes (correct answer)
  4. Normal cell cycle progression since p21 degradation is not required for DNA damage responses
  5. Immediate apoptosis because excessive p21 levels trigger caspase activation cascades
Explanation: When you encounter questions about cell cycle regulation and DNA damage responses, focus on understanding how checkpoint proteins like p21 coordinate these critical processes. The p21 protein serves as a crucial cell cycle brake, particularly at the G1/S checkpoint. When DNA damage occurs, p53 activates p21 transcription, and p21 then binds to and inhibits cyclin E-Cdk2 and cyclin A-Cdk2 complexes. This inhibition prevents cells from entering S phase until DNA repair is complete. Normally, p21 levels are tightly regulated through degradation pathways, but the experimental compound blocks this degradation. With stabilized p21 that cannot be degraded, the protein accumulates and maintains prolonged inhibition of cyclin-Cdk complexes. This creates an extended G1 arrest, giving cells more time for DNA repair before attempting replication. Answer C correctly identifies this outcome. Answer A incorrectly suggests p21 promotes cyclin E-Cdk2 complex formation, when p21 actually inhibits these complexes. Answer B wrongly claims p21 activates checkpoint kinases—p21 is actually downstream of these kinases in the damage response pathway. Answer D fails to recognize that preventing p21 degradation fundamentally alters the normal checkpoint response, making the outcome anything but normal. Remember that p21 functions as a molecular brake pedal for the cell cycle. When you see questions about compounds affecting p21 stability, think about whether the treatment would strengthen or weaken this braking mechanism and how that impacts cell cycle progression.

Question 3

A mutant cell line exhibits normal cyclin D expression and Rb phosphorylation in early G1, but fails to synthesize DNA despite adequate cyclin E levels. Analysis reveals that Cdk2 remains phosphorylated on threonine 14. What is the most likely defect in these cells?

  1. Overexpression of Wee1 kinase that phosphorylates Cdk2 at inhibitory sites throughout the cell cycle
  2. Loss of Cdc25A phosphatase activity required for Cdk2 dephosphorylation and activation (correct answer)
  3. Defective cyclin E nuclear localization preventing cyclin E-Cdk2 complex assembly
  4. Constitutive expression of p27 protein that sequesters cyclin E away from Cdk2
  5. Mutation in the Cdk2 ATP-binding domain that prevents kinase autophosphorylation
Explanation: When you encounter cell cycle questions involving DNA synthesis failure, focus on the G1/S transition machinery. This transition requires active Cdk2-cyclin E complexes to phosphorylate substrates that initiate DNA replication. The key clue here is that Cdk2 remains phosphorylated on threonine 14, an inhibitory phosphorylation site. For Cdk2 to become active, it must be dephosphorylated at this site by Cdc25A phosphatase. Since cyclin E levels are adequate and the cells progress normally through early G1, the problem isn't cyclin availability or cell cycle entry—it's specifically Cdk2 activation. Loss of Cdc25A phosphatase activity (B) would prevent this essential dephosphorylation, leaving Cdk2 inactive despite proper cyclin E binding. Option A is incorrect because Wee1 kinase primarily targets Cdk1, not Cdk2, and mainly functions during the G2/M transition. Option C doesn't fit because if cyclin E couldn't localize to the nucleus, you wouldn't have adequate cyclin E levels available for complex formation as stated in the question. Option D misrepresents p27's mechanism—p27 binds to and inhibits the cyclin E-Cdk2 complex directly rather than sequestering cyclin E away from Cdk2, and this wouldn't explain the specific threonine 14 phosphorylation pattern. For cell cycle questions, always trace the phosphorylation cascade. When you see persistent inhibitory phosphorylation on a Cdk, immediately consider whether the activating phosphatases (Cdc25 family) are functional—they're often the rate-limiting step in cell cycle progression.

Question 4

During S phase, a cell experiences replication fork stalling at a damaged DNA template. Which combination of cyclin-Cdk regulation would be most appropriate for maintaining genomic stability?

  1. Increased cyclin A-Cdk2 activity to accelerate replication fork progression past the damage
  2. Maintained cyclin A-Cdk2 activity with simultaneous activation of checkpoint kinases (correct answer)
  3. Complete inhibition of all cyclin-Cdk complexes to halt replication until damage is repaired
  4. Enhanced cyclin B-Cdk1 activity to promote early mitotic entry before damage accumulates
  5. Selective degradation of cyclin A while maintaining cyclin E-Cdk2 for continued origin firing
Explanation: When you encounter questions about DNA replication problems and cell cycle control, focus on how cells balance the need to complete replication with the imperative to maintain genomic integrity through checkpoint mechanisms. During S phase, replication fork stalling at DNA damage triggers the intra-S phase checkpoint, a critical quality control mechanism. The appropriate response involves maintaining cyclin A-Cdk2 activity (which is essential for ongoing S phase processes) while simultaneously activating checkpoint kinases like ATR and Chk1. This combination allows the cell to continue replicating undamaged portions of the genome while coordinating repair of the damaged region. The checkpoint kinases slow replication fork progression, activate DNA repair pathways, and prevent premature entry into mitosis until the damage is resolved. Choice A is problematic because simply accelerating replication past damage would lead to mutations, chromosome breaks, or incomplete replication—exactly what checkpoint mechanisms evolved to prevent. Choice C represents an overreaction; completely halting all cyclin-Cdk activity would stop replication entirely, including at undamaged sites, which is inefficient and unnecessary. Choice D is particularly dangerous because activating cyclin B-Cdk1 would push the cell toward mitosis with unrepaired DNA damage, leading to chromosome instability and potential cell death. Remember that checkpoint mechanisms don't typically shut down the entire cell cycle—they fine-tune it. Look for answers that describe coordinated responses involving both continued essential processes and activated surveillance mechanisms, rather than simple "stop" or "go faster" solutions.

Question 5

A researcher treats cells with roscovitine, a compound that specifically inhibits Cdk2 and Cdk1 but not Cdk4/6. If these cells are analyzed after 24 hours of treatment, which cell cycle distribution pattern would be most expected?

  1. Accumulation in early G1 phase due to inability to phosphorylate Rb protein
  2. Arrest at the G1/S boundary with elevated cyclin E levels but inactive Cdk2 (correct answer)
  3. Normal progression through G1 and S phase with arrest only in G2/M
  4. Complete cell cycle arrest in all phases due to loss of essential kinase activities
  5. Accelerated cell cycle progression due to loss of checkpoint control mechanisms
Explanation: When you encounter questions about cell cycle inhibitors, focus on which specific cyclins and CDKs control each checkpoint transition. Different CDK complexes have distinct roles at different phases. Roscovitine's selective inhibition of Cdk2 and Cdk1 (but not Cdk4/6) creates a specific arrest pattern. Since Cdk4/6 remains functional, cells can still phosphorylate Rb protein and progress through early G1 into late G1. However, the G1/S transition absolutely requires active Cdk2-cyclin E complexes to initiate DNA replication. With Cdk2 inhibited by roscovitine, cells accumulate at this boundary. The cyclin E levels actually increase because the cell continues receiving growth signals and producing cyclins, but the inactive Cdk2 cannot form functional kinase complexes. Option A is incorrect because Cdk4/6 (which remains active) is responsible for Rb phosphorylation, not Cdk2. Option C misses that Cdk2 is essential for S phase entry - cells wouldn't progress normally through G1 and S if Cdk2 is inhibited. Option D overstates the effect since functional Cdk4/6 allows early cell cycle progression to continue. The key insight is that cells will progress as far as their functional CDKs allow, then arrest at the first checkpoint requiring an inhibited kinase. Since Cdk4/6 works but Cdk2 doesn't, arrest occurs at G1/S. Study tip: Memorize the CDK-checkpoint pairs: Cdk4/6 for early G1, Cdk2 for G1/S transition, and Cdk1 for G2/M. This pattern appears frequently on cell biology exams.

Question 6

Cells expressing a temperature-sensitive mutant of Cdc25C phosphatase are shifted from permissive (30°C) to restrictive temperature (39°C) during G2 phase. After 4 hours at the restrictive temperature, which molecular state would these cells most likely exhibit?

  1. Accumulated cyclin B with active Cdk1 and normal progression into mitosis
  2. Degraded cyclin B due to premature APC/C activation in the absence of Cdc25C
  3. Accumulated cyclin B bound to inactive, phosphorylated Cdk1 in G2 arrest (correct answer)
  4. Loss of cyclin B-Cdk1 complex formation due to defective Cdc25C chaperone activity
  5. Hyperactivated Cdk1 leading to premature mitotic entry with incomplete DNA replication
Explanation: When you encounter questions about temperature-sensitive mutants and cell cycle checkpoints, focus on understanding how specific proteins control transitions between cell cycle phases. Cdc25C phosphatase is crucial for the G2/M transition because it activates Cdk1 by removing inhibitory phosphate groups. At the restrictive temperature, the mutant Cdc25C becomes non-functional. During normal G2 phase, cells accumulate cyclin B, which binds to Cdk1. However, Cdk1 remains inactive due to inhibitory phosphorylation by Wee1 kinase. Cdc25C normally removes these phosphate groups to activate the cyclin B-Cdk1 complex, allowing mitotic entry. Without functional Cdc25C, cells continue synthesizing cyclin B, but the Cdk1 remains phosphorylated and inactive, creating a G2 arrest with accumulated cyclin B bound to inactive Cdk1. Option A is wrong because Cdk1 cannot become active without Cdc25C phosphatase activity. Option B incorrectly suggests APC/C activation - this complex only becomes active later in mitosis and requires active Cdk1 to initiate its function. The APC/C doesn't activate prematurely just because Cdc25C is defective. Option D misrepresents Cdc25C's function - it's a phosphatase, not a chaperone involved in complex formation. The correct answer is C: accumulated cyclin B bound to inactive, phosphorylated Cdk1 in G2 arrest. Remember that cell cycle checkpoints often involve phosphorylation cascades. When studying checkpoint controls, always trace through the phosphorylation states of key regulatory proteins and identify which enzymes add or remove phosphate groups.

Question 7

A drug screening identifies a compound that selectively degrades cyclin A without affecting other cyclins. If this compound is added to synchronized cells just as they begin S phase, which consequence would most likely occur?

  1. Immediate cell cycle arrest with incomplete DNA replication and activation of ATR signaling (correct answer)
  2. Normal S phase completion followed by arrest at the G2/M transition
  3. Accelerated S phase progression due to loss of cyclin A-mediated origin licensing control
  4. Bypass of S phase with direct progression from G1 to mitosis
  5. Compensatory upregulation of cyclin E expression to maintain Cdk2 activity
Explanation: When you encounter questions about cyclin degradation and cell cycle timing, focus on the essential role each cyclin plays at specific checkpoints and what happens when those functions are disrupted. Cyclin A is crucial for S phase progression and DNA replication. It forms active kinase complexes (cyclin A-CDK2) that phosphorylate key replication proteins and maintain replication fork stability. If cyclin A is selectively degraded just as cells enter S phase, the replication machinery loses critical regulatory support. Without functional cyclin A-CDK complexes, replication forks become unstable, DNA synthesis stalls, and replication stress occurs. This triggers the ATR (ATM and Rad3-related) checkpoint pathway, which detects single-stranded DNA and stalled replication forks, leading to immediate cell cycle arrest. Answer B is incorrect because cells cannot complete S phase normally without cyclin A - the arrest occurs during S phase, not after it. Answer C misunderstands cyclin A's function; it doesn't control origin licensing (that's cyclin E and other factors) but rather supports ongoing replication, so its loss slows rather than accelerates S phase. Answer D is biologically impossible since cells cannot bypass S phase - DNA must be replicated before mitosis, and the checkpoints prevent this dangerous scenario. The correct answer is A because cyclin A degradation during S phase entry causes immediate replication problems, incomplete DNA synthesis, and ATR-mediated arrest. Study tip: Remember that each cyclin has a specific "window" of activity - disrupting a cyclin during its critical phase causes immediate problems, not delayed effects in later phases.

Question 8

Researchers observe that cells lacking functional p16 protein show enhanced sensitivity to Cdk4 inhibitors compared to normal cells. What mechanism best explains this paradoxical relationship?

  1. p16 normally activates alternative kinases that can compensate for Cdk4 loss
  2. Cells without p16 become addicted to high Cdk4 activity and cannot adapt to its inhibition (correct answer)
  3. p16 deficiency causes constitutive DNA damage that requires Cdk4 for repair processes
  4. Loss of p16 leads to cyclin D accumulation that makes cells more dependent on Cdk4
  5. p16-deficient cells have defective apoptosis pathways that normally rescue Cdk4 inhibition
Explanation: This question tests your understanding of oncogene addiction—a phenomenon where cancer cells become dependent on the very proteins they've dysregulated. When you see questions about tumor suppressors and drug sensitivity, think about how losing normal growth controls can create new vulnerabilities. The p16 protein normally acts as a brake on cell division by inhibiting Cdk4, which drives cells from G1 into S phase. When p16 is lost, cells lose this critical checkpoint control and become heavily reliant on Cdk4 to maintain their rapid proliferation. This creates a state of "oncogene addiction"—the cells have rewired their growth machinery around high Cdk4 activity and cannot survive when it's suddenly removed. Normal cells, with intact p16, maintain multiple layers of growth control and can better tolerate Cdk4 inhibition. Answer A incorrectly suggests p16 activates compensatory kinases, but p16 is actually an inhibitor that blocks kinases. Answer C mischaracterizes the relationship—while p16 loss can contribute to genomic instability, Cdk4 isn't primarily a DNA repair enzyme. Answer D contains a grain of truth about cyclin D accumulation but misses the key point about addiction; it's not just dependence on Cdk4, but the inability to adapt when that dependence is disrupted. Remember that cancer cells often become paradoxically vulnerable to inhibiting the very pathways they've overactivated. This principle of oncogene addiction explains why some cancer drugs work better on tumor cells than normal cells—look for this theme in cell biology questions about cancer therapeutics.

Question 9

In an experimental system, cyclin E is fused to a protein degradation signal that causes its destruction specifically during S phase. How would this modification most likely affect cell cycle progression?

  1. Normal G1/S transition followed by prolonged S phase due to insufficient Cdk2 activity (correct answer)
  2. Inability to initiate S phase because cyclin E is required for origin firing
  3. Accelerated S phase progression due to enhanced cyclin A expression
  4. Normal S phase completion with arrest in G2 due to premature cyclin E loss
  5. Immediate apoptosis upon S phase entry due to conflicting cell cycle signals
Explanation: When analyzing cell cycle regulation questions, focus on the timing and essential functions of each cyclin-Cdk complex. Cyclin E-Cdk2 is crucial for the G1/S transition and early S phase events, while cyclin A-Cdk2 takes over for S phase progression and completion. In this experimental setup, cyclin E can still accumulate normally during G1 and trigger S phase entry by phosphorylating key substrates like Rb protein and activating origin licensing. However, once S phase begins, the degradation signal destroys cyclin E, leaving cells with insufficient Cdk2 activity to efficiently complete DNA replication. While cyclin A-Cdk2 can partially compensate, the premature loss of cyclin E-Cdk2 activity disrupts optimal S phase progression, causing delays. Option B is incorrect because S phase initiation occurs before cyclin E destruction begins. The G1/S transition happens normally since cyclin E is present when needed. Option C misunderstands the relationship between cyclins E and A—losing cyclin E doesn't enhance cyclin A expression, and even if it did, this wouldn't accelerate S phase. Option D incorrectly assumes normal S phase completion; the reduced Cdk2 activity from cyclin E loss would impair, not maintain, normal S phase timing. The correct answer is A: cells successfully enter S phase but then experience prolonged DNA replication due to insufficient Cdk2 activity. Remember that cyclins have overlapping but distinct temporal requirements. Early loss of a cyclin affects the phases where it normally functions, not necessarily the transition into that phase.

Question 10

Cells are treated with a proteasome inhibitor during G1 phase, causing accumulation of p27 protein. Despite this treatment, some cells eventually enter S phase after prolonged culture. What mechanism most likely allows this checkpoint bypass?

  1. Spontaneous p27 degradation through proteasome-independent pathways
  2. Sequestration of excess p27 by increased cyclin D-Cdk4/6 complex formation (correct answer)
  3. Phosphorylation of p27 by accumulated Cdk2, creating a positive feedback loop
  4. Nuclear export of p27 protein removing it from cyclin-Cdk complexes
  5. Compensatory upregulation of cyclin E that overwhelms p27 inhibitory capacity
Explanation: When you encounter questions about cell cycle checkpoints and inhibitor treatments, focus on understanding how cells can adapt or find alternative pathways when their normal mechanisms are blocked. The G1/S checkpoint normally prevents cells from entering S phase until conditions are favorable. The p27 protein is a cyclin-dependent kinase inhibitor (CKI) that binds to and inactivates cyclin E-Cdk2 complexes, blocking S phase entry. Proteasome inhibitors prevent p27 degradation, so p27 accumulates and should maintain the cell cycle block. However, cells can bypass this block through sequestration. When cyclin D levels increase over time in culture, more cyclin D-Cdk4/6 complexes form. These complexes have a higher affinity for p27 than cyclin E-Cdk2 complexes do. The excess cyclin D-Cdk4/6 complexes essentially "soak up" the accumulated p27 protein, sequestering it away from cyclin E-Cdk2. This frees cyclin E-Cdk2 complexes to become active and drive S phase entry, explaining why answer B is correct. Answer A is wrong because proteasome-independent p27 degradation pathways are minimal and wouldn't significantly reduce p27 levels. Answer C incorrectly suggests Cdk2 can phosphorylate p27 when Cdk2 is actually inhibited by p27 binding. Answer D is incorrect because nuclear export wouldn't be the primary mechanism for overcoming checkpoint arrest. Remember: cells often have backup mechanisms and alternative pathways. When one route is blocked, look for how cellular processes might adapt through changes in protein levels, binding affinities, or compartmentalization.

Question 11

A mutation in APC/C prevents it from recognizing cyclin A as a substrate while maintaining its ability to target cyclin B normally. Cells harboring this mutation would most likely exhibit which defect?

  1. Inability to complete mitosis due to persistent cyclin A-Cdk1 activity during anaphase
  2. Failure to enter the next cell cycle due to accumulated cyclin A preventing origin licensing (correct answer)
  3. Normal mitosis but defective S phase progression in the subsequent cell cycle
  4. Accelerated progression through the next G1 phase due to residual cyclin A-Cdk2 activity
  5. Immediate apoptosis upon mitotic entry due to conflicting cyclin signals
Explanation: When analyzing APC/C mutations, focus on the timing and targets of cyclin degradation throughout the cell cycle. The APC/C (Anaphase Promoting Complex/Cyclosome) is crucial for ordered progression by degrading specific cyclins at precise moments. This mutation creates a selective defect: cyclin A persists while cyclin B degradation remains normal. Cyclin A-Cdk2 activity must be eliminated before cells can properly exit mitosis and prepare for the next cell cycle. When cyclin A accumulates due to failed APC/C recognition, it prevents origin licensing - the process that "loads" replication origins with the machinery needed for DNA synthesis. Origin licensing can only occur when CDK activity is low, but persistent cyclin A-Cdk2 maintains high CDK activity, blocking entry into the subsequent S phase. Answer A is incorrect because cyclin A doesn't partner with Cdk1 during anaphase - that's cyclin B's role, which remains unaffected by this mutation. Answer C misses the point entirely: the problem isn't defective S phase progression but rather the inability to even enter S phase due to failed origin licensing. Answer D incorrectly suggests accelerated G1 progression, but accumulated cyclin A actually prevents proper cell cycle advancement by blocking the transition from G1 to S phase. Remember that cyclin degradation timing is as critical as cyclin accumulation timing. When studying cell cycle control, always consider both what needs to be present AND what needs to be absent for each transition to occur properly.

Question 12

Researchers create a fusion protein linking cyclin D to a nuclear export signal that removes it from the nucleus during G1. What would be the primary consequence for cell cycle control in these cells?

  1. Enhanced G1/S transition due to reduced competition for Cdk binding sites
  2. Inability to phosphorylate Rb protein, causing permanent G1 arrest (correct answer)
  3. Compensatory activation of cyclin E-Cdk2 complexes that bypass the restriction point
  4. Normal cell cycle progression due to redundant cyclin D-independent pathways
  5. Accelerated progression to S phase due to loss of cyclin D-mediated checkpoints
Explanation: When you encounter questions about cell cycle modifications, focus on the specific roles of cyclins and their spatial requirements for function. Cyclin D operates in the nucleus during G1 phase, where it forms complexes with Cdk4/6 to phosphorylate the Rb protein—a critical step for cell cycle progression. By adding a nuclear export signal to cyclin D, researchers force this protein out of the nucleus where it cannot access its target, Rb protein. Without cyclin D-Cdk4/6 complexes phosphorylating Rb, the protein remains in its active, growth-suppressive state, permanently blocking the cell at the G1/S checkpoint. This creates an insurmountable barrier to DNA replication and cell division. Answer A incorrectly suggests that removing cyclin D would enhance G1/S transition. In reality, cyclin D is essential for this transition, not inhibitory to it. Answer C proposes that cyclin E-Cdk2 could compensate, but these complexes act downstream of cyclin D-Cdk4/6 and cannot phosphorylate Rb protein effectively on their own. The restriction point specifically requires cyclin D function. Answer D suggests normal progression through redundant pathways, but cyclin D's role in Rb phosphorylation is largely non-redundant—other cyclins cannot fully substitute for this specific function. For cell biology exams, remember that cyclin localization is crucial for function. When you see experimental manipulations affecting protein localization, always consider whether the protein can still access its targets and perform its essential molecular functions in the new cellular compartment.

Question 13

A drug specifically prevents the interaction between p27 and cyclin E-Cdk2 complexes without affecting p27 binding to cyclin D-Cdk4/6. Treatment of G1-arrested cells with this drug would most likely produce which outcome?

  1. Immediate progression to S phase despite continued p27 expression
  2. Continued G1 arrest because p27 still inhibits Cdk4/6 required for Rb phosphorylation (correct answer)
  3. Partial cell cycle progression with arrest at the G1/S boundary
  4. Accelerated degradation of p27 through Cdk2-mediated phosphorylation
  5. Compensatory upregulation of p21 to maintain cell cycle control
Explanation: When you encounter cell cycle regulation questions, focus on the sequential checkpoints and the specific roles of different cyclin-Cdk complexes. The G1/S transition requires two key steps: first, cyclin D-Cdk4/6 must phosphorylate Rb protein to release E2F transcription factors, then cyclin E-Cdk2 must complete S phase entry. The drug blocks p27 from inhibiting cyclin E-Cdk2 but leaves p27's inhibition of cyclin D-Cdk4/6 intact. Since Rb phosphorylation by Cdk4/6 is the essential first step for any S phase progression, cells remain arrested in G1. Even though Cdk2 activity could theoretically increase, it cannot function without the prior Rb inactivation that only Cdk4/6 can provide. Option A is incorrect because S phase entry absolutely requires Rb phosphorylation by Cdk4/6, which remains blocked by p27. Option C misunderstands the sequential nature—you cannot reach the G1/S boundary without first completing Cdk4/6-mediated Rb phosphorylation. Option D confuses cause and effect; while Cdk2 can phosphorylate p27 for degradation, this occurs after S phase commitment, not before, and the continued Cdk4/6 inhibition prevents reaching that point. Remember that cell cycle progression follows a strict hierarchy: cyclin D-Cdk4/6 activity is prerequisite for cyclin E-Cdk2 function. When analyzing cell cycle inhibition scenarios, always trace through this sequential requirement—blocking the earlier step trumps releasing the later one.

Question 14

Cells expressing a constitutively active mutant Cdc25A (resistant to checkpoint-mediated degradation) are exposed to UV radiation during S phase. Which consequence would most likely threaten genomic integrity?

  1. Premature mitotic entry with incompletely replicated DNA due to unregulated Cdk1 activation
  2. Accelerated replication fork progression through UV-damaged DNA templates (correct answer)
  3. Inappropriate origin firing leading to re-replication of damaged DNA segments
  4. Enhanced DNA repair due to sustained Cdk2 activity promoting repair protein recruitment
  5. Immediate cell death due to conflicting damage response and cell cycle signals
Explanation: When you encounter questions about cell cycle regulation and DNA damage responses, focus on how checkpoint proteins coordinate replication timing with DNA integrity surveillance. Cdc25A is a phosphatase that activates cyclin-dependent kinases (Cdks) by removing inhibitory phosphates. During normal S phase, Cdc25A is tightly regulated—when DNA damage occurs, checkpoint mechanisms rapidly degrade Cdc25A to slow replication and allow repair. A constitutively active, degradation-resistant mutant would bypass this critical safety mechanism. With unregulated Cdc25A activity after UV damage, Cdk2 remains highly active, driving replication machinery to continue synthesizing DNA even through UV-induced lesions like thymine dimers. This forced progression through damaged templates would incorporate mutations and create replication fork collapse, severely threatening genomic integrity. This makes option B correct. Option A is wrong because Cdc25A primarily regulates Cdk2 during S phase, not Cdk1 for mitotic entry. Option C misunderstands the mechanism—while inappropriate origin firing can occur, the primary threat is pushing existing forks through damage, not re-replication. Option D incorrectly suggests enhanced repair; actually, sustained Cdk2 activity typically inhibits repair by preventing the replication slowdown needed for proper damage response. Study tip: Remember that cell cycle checkpoints work by degrading positive regulators like Cdc25A. When you see "constitutively active" or "degradation-resistant" mutants in damage scenarios, think about what normally gets shut down for protection—usually it's the continuation of the current phase's processes, not progression to the next phase.

Question 15

A novel experimental approach involves expressing a dominant-negative version of Cdk1 that can bind cyclins but lacks kinase activity. In cells expressing this mutant during mitosis, which outcome would be most detrimental?

  1. Enhanced mitotic progression due to reduced cyclin-Cdk1 substrate phosphorylation
  2. Inability to maintain chromosome condensation leading to premature chromatin decondensation
  3. Normal mitosis because other kinases can compensate for Cdk1 function
  4. Mitotic arrest due to spindle checkpoint activation from unattached chromosomes (correct answer)
  5. Immediate reversal to interphase due to loss of mitotic kinase activity
Explanation: When you encounter questions about dominant-negative mutants in cell biology, think about how these proteins interfere with normal cellular processes by competing with wild-type proteins but lacking essential function. A dominant-negative Cdk1 that binds cyclins but lacks kinase activity would sequester cyclins away from functional Cdk1, drastically reducing active cyclin-Cdk1 complexes during mitosis. This creates a critical problem: without sufficient Cdk1 activity, cells cannot properly phosphorylate proteins required for spindle formation and chromosome attachment to kinetochores. The most detrimental outcome would be option D - mitotic arrest due to spindle checkpoint activation. When chromosomes fail to properly attach to spindle fibers (because of inadequate Cdk1-dependent spindle assembly), the spindle checkpoint remains active, preventing cells from progressing past metaphase. This leads to prolonged mitotic arrest and eventual cell death. Option A is backwards - reduced Cdk1 activity would impair, not enhance, mitotic progression. Option B describes a real consequence of lost Cdk1 function, but chromosome condensation defects are less immediately lethal than spindle checkpoint arrest. Option C ignores the unique, non-redundant roles of Cdk1 in mitosis - other kinases cannot fully compensate for cyclin B-Cdk1's essential functions in spindle dynamics and chromosome attachment. Study tip: For dominant-negative questions, always consider the downstream cascade effects. The most severe phenotype usually involves checkpoint activation or cell cycle arrest, which are fail-safe mechanisms that prevent cells from completing division with damaged components.

Question 16

Researchers engineer cells to express p21 that cannot be phosphorylated by Cdk2, making it resistant to degradation. When these cells encounter mild DNA damage during S phase, which adaptation would be most problematic for cell survival?

  1. Inability to complete DNA repair due to persistent cell cycle arrest
  2. Premature senescence activation due to prolonged p21-mediated growth inhibition
  3. Failure to resume cell cycle progression after successful DNA repair (correct answer)
  4. Enhanced apoptosis due to sustained p21-p53 positive feedback signaling
  5. Compensatory mutations that inactivate p21 function to restore proliferation
Explanation: When you encounter questions about engineered cell cycle proteins, focus on the normal regulatory mechanisms and what happens when they're disrupted. This question tests your understanding of how p21 normally functions in DNA damage checkpoints. In normal cells, p21 acts as a "brake" that stops the cell cycle when DNA damage is detected. Once repairs are complete, Cdk2 phosphorylates p21, targeting it for degradation so the cell can resume division. The engineered cells in this scenario have p21 that resists this normal degradation pathway. The key insight is that these cells can still perform DNA repair while arrested—p21 doesn't interfere with repair machinery. However, without the ability to degrade p21 after repairs are finished, the cells remain permanently stuck in arrest. This makes option C correct: the cells cannot resume normal division even after successful DNA repair because the "brake" (p21) cannot be released. Option A is incorrect because DNA repair can still occur during p21-mediated arrest—the arrest actually provides time for repair. Option B misunderstands the scenario; mild damage with successful repair wouldn't typically trigger senescence pathways. Option D incorrectly suggests p21 directly enhances apoptosis through p53 feedback, but p21 generally promotes cell survival by allowing repair time rather than triggering death pathways. Remember that cell cycle checkpoints have both "on" and "off" switches. Questions often test whether you understand that both activation and inactivation of checkpoint proteins must be properly regulated for normal cell function.

Question 17

In cancer cells with mutated p53, treatment with a Cdk4/6 inhibitor (palbociclib) often causes growth arrest, while normal cells with functional p53 show similar arrest but can eventually resume proliferation. What mechanism best explains this differential response?

  1. Cancer cells lack p21 induction capacity, making them more dependent on Cdk4/6 for Rb phosphorylation
  2. Normal cells can activate p53-mediated apoptosis pathways that cancer cells cannot access
  3. Cancer cells have defective DNA repair mechanisms that require continuous Cdk4/6 activity for maintenance
  4. Normal cells retain p53-dependent senescence programs that provide alternative growth control pathways (correct answer)
  5. Cancer cells express higher basal cyclin D levels that make them more sensitive to Cdk4/6 inhibition
Explanation: When analyzing how cells respond differently to targeted cancer therapies, focus on what cellular pathways remain intact versus which ones are disrupted by mutations. This question tests your understanding of how p53 status affects cell cycle control mechanisms beyond the primary target. The key insight is that normal cells have multiple layers of growth control. When Cdk4/6 is inhibited, normal cells initially arrest but can activate p53-dependent senescence pathways - permanent growth arrest programs that provide alternative tumor suppression. These senescent cells eventually adapt and may resume controlled proliferation through p53-mediated checkpoints. Cancer cells with mutated p53 lack these backup senescence programs, so they become trapped in the Cdk4/6 inhibition state with no alternative pathways for growth control. Choice A is incorrect because p21 induction depends on functional p53, so cancer cells with mutated p53 would actually have impaired p21 responses, not enhanced dependence on Cdk4/6 for Rb phosphorylation. Choice B reverses the scenario - it's actually the cancer cells that cannot access p53-mediated apoptosis, but this doesn't explain why normal cells eventually resume proliferation. Choice C incorrectly suggests Cdk4/6 has a direct role in DNA repair maintenance, when its primary function is cell cycle progression through G1/S transition. Remember that p53 is called "guardian of the genome" because it coordinates multiple cellular responses to stress. In cancer therapy questions, always consider what backup pathways remain functional when the primary target is inhibited.

Question 18

In a cell line with defective Wee1 kinase activity, what cellular adaptation would be most critical for maintaining genomic stability during cell division?

  1. Increased Cdc25 phosphatase activity to compensate for lost Wee1 function
  2. Enhanced DNA repair mechanisms to fix replication errors before mitosis
  3. Upregulation of checkpoint proteins that can delay mitosis until DNA synthesis is complete (correct answer)
  4. Reduced cyclin B expression to prevent premature Cdk1 activation
  5. Constitutive p53 activation to monitor for DNA damage throughout the cell cycle
Explanation: When you encounter questions about cell cycle defects, focus on how cells maintain genomic stability through checkpoint mechanisms. Wee1 kinase normally prevents premature entry into mitosis by phosphorylating and inactivating Cdk1 until DNA replication is complete. Without functional Wee1, cells lose this critical brake on mitotic entry, creating a dangerous situation where cells might attempt division before DNA synthesis finishes. The most effective cellular adaptation would be upregulating checkpoint proteins that can independently monitor DNA replication status and delay mitosis until it's safe to proceed (C). These backup checkpoint mechanisms, particularly those involving ATR kinase and Chk1, can sense incomplete replication and maintain the G2/M block even without Wee1. Option A is counterproductive—increasing Cdc25 phosphatase would worsen the problem by further promoting Cdk1 activation when you need the opposite effect. Option B, while DNA repair is important, addresses damage after it occurs rather than preventing the fundamental timing problem that causes genomic instability. Enhanced repair can't compensate for cells dividing with incompletely replicated chromosomes. Option D seems logical but is insufficient—simply reducing cyclin B might slow cell division overall but doesn't provide the precise checkpoint control needed to ensure DNA synthesis completion before mitosis. For cell cycle questions, remember that genomic stability depends on proper temporal coordination. When one checkpoint mechanism fails, cells typically rely on redundant checkpoint pathways rather than trying to recreate the exact same function through different proteins.

Question 19

A cell line is engineered to express a non-degradable form of cyclin B that lacks its destruction box. When these cells enter mitosis, which outcome would be most problematic for cell viability?

  1. Inability to condense chromosomes due to insufficient Cdk1 activation
  2. Failure to assemble a functional mitotic spindle apparatus
  3. Inability to exit mitosis and complete cytokinesis after chromosome separation (correct answer)
  4. Premature activation of DNA replication during metaphase
  5. Loss of nuclear envelope breakdown required for chromosome attachment
Explanation: When you encounter questions about cell cycle regulation, focus on the critical checkpoints that ensure proper cell division. Cyclin B and its partner kinase Cdk1 form the key regulatory complex that drives cells through mitosis. Cyclin B normally accumulates during S and G2 phases, then gets rapidly degraded at the end of mitosis through its destruction box sequence. This degradation is essential because it inactivates Cdk1, allowing cells to exit mitosis. Without a functional destruction box, cyclin B cannot be degraded, meaning Cdk1 remains active indefinitely. The correct answer is C because persistent Cdk1 activity prevents mitotic exit. Even after chromosomes separate properly, the cell cannot proceed through anaphase to telophase and cytokinesis. The cell becomes trapped in a mitotic-like state, which is lethal because it cannot return to interphase to resume normal cellular functions. Answer A is incorrect because non-degradable cyclin B would actually provide sustained Cdk1 activation, not insufficient activation. Answer B is wrong because spindle assembly occurs early in mitosis when cyclin B-Cdk1 activity is beneficial and necessary. Answer D is incorrect because active Cdk1 actually inhibits DNA replication machinery, preventing premature S phase entry during mitosis. Remember that cyclin destruction is just as important as cyclin accumulation in cell cycle control. Questions about "non-degradable" cell cycle proteins almost always test whether you understand that cells must be able to turn off these regulatory signals to progress normally.

Question 20

A novel Cdk inhibitor protein is discovered that specifically targets the cyclin-binding domain of Cdk1 but not its kinase domain. Overexpression of this inhibitor in cultured cells would most likely result in which phenotype?

  1. G1 arrest due to interference with Cdk4/6-cyclin D complex formation
  2. S phase delay caused by disruption of cyclin A-Cdk1 interactions
  3. G2 arrest with accumulated but inactive cyclin B in the cytoplasm (correct answer)
  4. Mitotic catastrophe due to formation of kinase-active but unregulated Cdk1
  5. Normal cell cycle progression with enhanced checkpoint sensitivity
Explanation: When you encounter questions about cell cycle regulators, focus on the specific timing and location of cyclin-Cdk complexes throughout the cell cycle. This question tests your understanding of how protein-protein interactions control cell cycle progression. The inhibitor specifically blocks cyclin binding to Cdk1 without affecting its kinase domain. Cdk1 pairs with cyclin B to drive cells through the G2/M transition and into mitosis. When cyclin B accumulates during G2 phase but cannot bind to Cdk1 due to the inhibitor, the cyclin B-Cdk1 complex cannot form. Without this active complex, cells cannot pass the G2/M checkpoint and become arrested in G2 phase. The cyclin B protein would still be synthesized and accumulate in the cytoplasm (where it normally resides before nuclear entry), but it would remain inactive because it cannot associate with its Cdk partner. Answer A is incorrect because Cdk1 doesn't regulate the G1/S transition—that's controlled by Cdk4/6-cyclin D and Cdk2-cyclin E complexes. Answer B is wrong because while cyclin A does interact with Cdk1 during S phase, the primary phenotype would be G2 arrest, not S phase delay, since cells could still progress through S phase using Cdk2-cyclin A. Answer D is incorrect because blocking cyclin binding would prevent kinase activation, not create unregulated active kinase—Cdk1 requires cyclin binding for full activation. Remember: Cdk1-cyclin B is the master regulator of mitotic entry. Disrupting this specific interaction always results in G2 arrest with accumulated inactive cyclins.